Reference
- Rao M, et al. Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: A case report. Oncotarget 10: 6038-6042, No. 57, 15 Oct 2019. Available from: URL: http://doi.org/10.18632/oncotarget.27203 - USA
Copyright information
© Springer International Publishing AG 2019